GLUL and irritable bowel syndrome: MiR-29a had a complementary site in the 3′-UTRs of the glutamine ligase gene, which could lead to reduced glutamine synthetase levels, increased intestinal permeability and chronic visceral pain in IBS patients (Zhou et al., 2010).